Detalles de la búsqueda
1.
Chagas disease.
Lancet
; 403(10422): 203-218, 2024 Jan 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38071985
2.
Use of PET/CT to detect myocardial inflammation and the risk of malignant arrhythmia in chronic Chagas disease.
J Nucl Cardiol
; 30(6): 2702-2711, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37605061
3.
Autonomic denervation, myocardial hypoperfusion and fibrosis may predict ventricular arrhythmia in the early stages of Chagas cardiomyopathy.
J Nucl Cardiol
; 30(6): 2379-2388, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37226005
4.
Discontinuing vs continuing ACEIs and ARBs in hospitalized patients with COVID-19 according to disease severity: Insights from the BRACE CORONA trial.
Am Heart J
; 249: 86-97, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35405099
5.
Cost-effectiveness of an exercise-based cardiovascular rehabilitation program in patients with chronic Chagas cardiomyopathy in Brazil: An analysis from the PEACH study.
Trop Med Int Health
; 27(7): 630-638, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35644993
6.
Exercise training improves microvascular function in patients with Chagas heart disease: Data from the PEACH study.
Microvasc Res
; 134: 104106, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33212111
7.
Factors related to the discontinuation and mortality rates of a cardiac rehabilitation programme in patients with Chagas disease: a 6-year experience in a Brazilian tertiary centre.
Trop Med Int Health
; 26(3): 355-365, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33305528
8.
Impact of pharmaceutical care on the quality of life of patients with heart failure due to chronic Chagas disease: Randomized clinical trial.
Br J Clin Pharmacol
; 86(1): 143-154, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31659776
9.
A cardiac rehabilitation exercise program potentially inhibits progressive inflammation in patients with severe Chagas cardiomyopathy: A pilot single-arm clinical trial.
J Res Med Sci
; 25: 18, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32174990
10.
Can PET/CT be useful in predicting ventricular arrhythmias in Chagas Disease?
J Nucl Cardiol
; 27(6): 2417-2420, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31898002
11.
A clinical adverse drug reaction prediction model for patients with chagas disease treated with benznidazole.
Antimicrob Agents Chemother
; 58(11): 6371-7, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25114135
12.
Effect of an exercise-based cardiac rehabilitation program on quality of life of patients with chronic Chagas cardiomyopathy: results from the PEACH randomized clinical trial.
Sci Rep
; 14(1): 8208, 2024 04 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38589582
13.
A multicenter comparative study of the performance of four rapid immunochromatographic tests for the detection of anti-Trypanosoma cruzi antibodies in Brazil.
Front Med (Lausanne)
; 10: 1031455, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36936214
14.
Comparative effects of a cardiovascular rehabilitation program on functional capacity in patients with chronic chagasic cardiomyopathy with or without heart failure.
Disabil Rehabil
; 45(1): 51-56, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35007459
15.
How Cardiac Fibrosis Assessed via T1 Mapping Is Associated with Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease.
J Clin Med
; 12(23)2023 Nov 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38068433
16.
Acute and subacute hemodynamic responses and perception of effort in subjects with chronic Chagas cardiomyopathy submitted to different protocols of inspiratory muscle training: a cross-over trial.
Disabil Rehabil
; 44(8): 1305-1312, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32779544
17.
Impact of COVID-19 In-hospital Mortality in Chagas Disease Patients.
Front Med (Lausanne)
; 9: 880796, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35615087
18.
Corrigendum: Impact of COVID-19 in-hospital mortality in chagas disease patients.
Front Med (Lausanne)
; 9: 963805, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35957851
19.
New Contributions to the Elimination of Chagas Disease as a Public Health Problem: Towards the Sustainable Development Goals by 2030.
Trop Med Infect Dis
; 6(1)2021 Feb 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33670425
20.
Prevalence of metabolic syndrome and associated factors among patients with chronic Chagas disease.
PLoS One
; 16(4): e0249116, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33798206